LevelJump Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services, today announced that it intends to complete a non-brokered private placement (the "Offering") of up to 15,000,000 common shares (the "Shares") of the Company at a price of $0.05 per Share, for gross proceeds of up to $750,000. Completion of the Offering is subject to the approval of the TSX Ventu
Healthcare and Hospitals, Health
2026-04-07 6:18 PM EDT | LevelJump Healthcare Corp.
Akanda Adjourns Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, April 27, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-07 8:30 AM EDT | Akanda Corp
Canadian Ophthalmologists Highlight Seasonal Environmental Risks to Eye Health
Ottawa, Ontario--(Newsfile Corp. - April 7, 2026) - Ophthalmologists across Canada are observing the impact of seasonal environmental exposures — including ultraviolet (UV) radiation, wildfire smoke, and airborne allergens — on patients' ocular health and visual comfort. As these factors intensify during the spring and summer months, the Canadian Ophthalmological Society (COS) is underscoring the importance of awareness and preventive care to reduce both immediate irritation and l
Healthcare and Hospitals, Pharmaceuticals, Health
2026-04-07 7:30 AM EDT | Canadian Ophthalmological Society (COS)
Les ophtalmologistes canadiens mettent en garde contre les risques environnementaux saisonniers pour la santé oculaire
Ottawa, Ontario--(Newsfile Corp. - 7 avril 2026) - Partout au pays, les ophtalmologistes constatent les effets des expositions environnementales saisonnières, notamment le rayonnement ultraviolet (UV), la fumée des feux de forêt et les allergènes en suspension dans l'air - sur la santé oculaire et le confort visuel des patients. À mesure que ces facteurs s'intensifient au printemps et à l'été, la Société canadienne d'ophtalmologie (SCO) s
Healthcare and Hospitals, Pharmaceuticals, Health
2026-04-07 7:30 AM EDT | Canadian Ophthalmological Society (COS)
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that Filament Health Corp. ("Filament") signed three new license agreements and completed two research shipments during March 2026, further expanding the global cl
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-04-07 7:30 AM EDT | Red Light Holland Corp.
TelyRx Holdings Inc. to Commence Trading on the Toronto Stock Exchange Effective April 7, 2026
Clearwater, Florida--(Newsfile Corp. - April 7, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced that its subordinate voting shares will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "TELY" effective Tuesday, April 7, 2026. This milestone follows the completion of its go-public transaction pursuant to the combination with Apolo V Acquisiti
Healthcare and Hospitals, Health
2026-04-07 7:00 AM EDT | TelyRx
TempraMed Announces Additional Granted Brazilian Patent for Newest VIVI Box Product
Highlights Brazilian patent officially granted by the Brazilian Patent Office Covers core innovations underpinning TempraMed's VIVI Box™ multi-medication storage platform expected to market end of 2026 Strengthens the Company's intellectual property position in one of the world's largest healthcare and consumer markets Supports commercialization strategy and strategic engagement with applia
Technology, Biotechnology, Pharmaceuticals, Health
2026-04-07 7:00 AM EDT | TempraMed Technologies Ltd.
Edison Issues Report on MindMaze Therapeutics (MMTX)
London, United Kingdom--(Newsfile Corp. - April 7, 2026) - Edison issues report on MindMaze Therapeutics (SIX: MMTX). MindMaze Therapeutics is a commercial-stage health technology company pioneering AI-driven digital neurotherapeutic solutions for treatment and recovery after neurological events such as stroke and traumatic brain injury (TBI). Its unique, integrated and coordinated platform spans the full continuum of care from acute treatment to at-home recovery, providing differentiat
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-04-07 5:41 AM EDT | Edison Group
Esthetique Dentistry of Ashburn Opens State-of-the-Art Cosmetic & Implant Dental Center in Northern Virginia
Ashburn, Virginia--(Newsfile Corp. - April 6, 2026) - Esthetique Dentistry of Ashburn, one of Northern Virginia's most recognized dental practices, is proud to announce the grand opening of its newly built, state-of-the-art facility at 44121 Leesburg Pike, Suite 225, Ashburn, VA 20147. The practice, now operating as the Cosmetic & Implant Dental Center of Northern Virginia, will host a Grand Inauguration & Open House on Thursday, April 9th, 2026 from 3:00 PM to 7:00 P
2026-04-06 10:17 PM EDT | Esthetique Dentistry
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Burlington, Ontario--(Newsfile Corp. - April 6, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on March 31, 2026. The Company expects to issue the Common Shares no later
2026-04-06 4:30 PM EDT | Rapid Dose Therapeutics Corp.
CitrusBurn Introduces Updated 2026 Natural Formula as Reviews Highlight User Experiences
Washington, D.C.--(Newsfile Corp. - April 4, 2026) - CitrusBurn today announced the release of its updated 2026 formula, designed to support natural metabolic function as part of a daily routine.
2026-04-04 3:24 PM EDT | CitrusBurn Labs, LLC
Audifort Introduces Updated 2026 Natural Formula as Reviews Highlight User Experiences
Washington, D.C.--(Newsfile Corp. - April 4, 2026) - Audifort today announced the release of its updated 2026 formula, designed to support natural hearing health and auditory wellness as part of a daily routine.
2026-04-04 12:24 PM EDT | Audifort LLC
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of methadone hydrochloride 5 mg and 10 mg tablets. Methadone tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic that cannot be adequately treated with alternative o
Healthcare and Hospitals, Pharmaceuticals, Health
2026-04-02 8:00 AM EDT | Elite Pharmaceuticals, Inc.
PreveCeutical Adopts Semi-Annual Financial Reporting
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected to rely on Coordinated Blanket Order 51-933 and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-93 allows eligible venture issuers listed on the Canadian Securities Exchange (the "CSE") to voluntarily move from a quarterly to a semi
Biotechnology, Pharmaceuticals, Health
2026-04-01 4:00 PM EDT | PreveCeutical Medical Inc.
Jam For Cam Raises More Than $1.2 Million for Skin Cancer Research and Awareness with Jam in the Streets
Athens, Georgia--(Newsfile Corp. - April 1, 2026) - Athens-based nonprofit organization Jam For Cam raised more than $1.2 million for skin cancer research and detection with its Jam in the Streets festival Saturday, which attracted more than 25,000 people to Downtown Athens. Jam in the Streets featured 19 performances across seven stages, headlined by Goose. The festival honored the dream of Cameron Fearon, a University of Georgia student who passed away at 19 from metastatic melanoma.
2026-04-01 2:48 PM EDT | Jam For Cam
Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status
Winter Park, Florida--(Newsfile Corp. - April 1, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced key highlights from its Form 10-K annual report for the year ended December 31, 2025. The filing marks a pivotal year of operational expansion following the company's successful transition from a dormant shell to an active player in the high-growth regenerative healthcare sector. In 2025, Adi
Healthcare and Hospitals, Health
2026-04-01 10:07 AM EDT | Adia Nutrition Inc.
Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that, through Filament Health Corp. ("Filament"), it will support the Carhart-Harris Lab ("CHL") at the University of California, San Francisco ("UCSF") by providing instructions on how to participate in the CHL Global Psychedelic Study to all researchers and clinicians receiving PEX010, including clinical trials and compassionate us
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-04-01 9:20 AM EDT | Red Light Holland Corp.
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technology, Biotechnology, Investment Banking, Health
2026-04-01 7:30 AM EDT | Bloom Burton & Co. Inc.
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026. Reported positive Phase II ARCHER data showing CardiolRx™ significantly reduced left ventricular mass in patients with acute myocarditis; results published in ESC Heart Failure. Advanced CRD-38 program, a novel next generation drug intended for use in heart failure an
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-01 7:27 AM EDT | Cardiol Therapeutics Inc.
Scryb Reports 2026 AGM Results and Welcomes Veteran Capital Markets and Finance Directors
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce the results of its Annual General Meeting of shareholders (the "AGM") held on March 31, 2026. All resolutions presented at the AGM received overwhelming shareholder support, with more than 99% of votes cast in favour. This strong approval reflects shareholder confidence in the Company's management team, leadership, refreshed strategy, and long-
Biotechnology, Healthcare and Hospitals, Health
2026-04-01 7:06 AM EDT | Scryb Inc.